Literature DB >> 19212943

The psychoneuroimmunology of depression.

Brian E Leonard1, Ayemu Myint.   

Abstract

Chronic stress, by initiating changes in the hypothalamic-pituitary-adrenal (HPA) axis and the immune system, acts as a trigger for anxiety and depression. There is experimental and clinical evidence that the rise in the concentration of pro-inflammatory cytokines and glucocorticoids, which occurs in a chronically stressful situation and also in depression, contribute to the behavioural changes associated with depression. A defect in serotonergic function is associated with these hormonal and immune changes. Neurodegenerative changes in the hippocampus, prefrontal cortex and amygdalae are the frequent outcome of the changes in the HPA axis and the immune system. Such changes may provide evidence for the link between chronic depression and dementia in later life.

Entities:  

Mesh:

Year:  2009        PMID: 19212943     DOI: 10.1002/hup.1011

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  54 in total

1.  Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.

Authors:  Peggy Jungke; Gigi Ostrow; Jian-Liang Li; Sharon Norton; Karen Nieber; Olaf Kelber; Veronika Butterweck
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

2.  Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression.

Authors:  Ali A Weinstein; Patricia A Deuster; Jennifer L Francis; Robert W Bonsall; Russell P Tracy; Willem J Kop
Journal:  Biol Psychol       Date:  2010-01-29       Impact factor: 3.251

Review 3.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

4.  Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.

Authors:  Rukiye Çolak Sivri; Ayhan Bilgiç; İbrahim Kılınç
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-01-04       Impact factor: 4.785

5.  Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.

Authors:  Clare J Wilhelm; Aaron Murphy-Crews; Daniel J Menasco; Marilyn S Huckans; Jennifer M Loftis
Journal:  Neuropharmacology       Date:  2011-08-04       Impact factor: 5.250

6.  Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder.

Authors:  Michael R Jarcho; George M Slavich; Hana Tylova-Stein; Owen M Wolkowitz; Heather M Burke
Journal:  Biol Psychol       Date:  2013-02-11       Impact factor: 3.251

7.  Personality traits and diabetes incidence among postmenopausal women.

Authors:  Juhua Luo; JoAnn E Manson; Julie C Weitlauf; Aladdin H Shadyab; Stephen R Rapp; Lorena Garcia; Junmei Miao Jonasson; Hilary A Tindle; Rami Nassir; Jean Wactawski-Wende; Michael Hendryx
Journal:  Menopause       Date:  2019-01-21       Impact factor: 2.953

Review 8.  Neurobiology of anxious depression: a review.

Authors:  Dawn F Ionescu; Mark J Niciu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

9.  Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients.

Authors:  Hooriyah S Rizavi; Xinguo Ren; Hui Zhang; Runa Bhaumik; Ghanshyam N Pandey
Journal:  Psychiatry Res       Date:  2016-04-22       Impact factor: 3.222

10.  Unemployment and ill health: a connection through inflammation?

Authors:  Jukka Hintikka; Soili M Lehto; Leo Niskanen; Anne Huotari; Karl-Heinz Herzig; Heli Koivumaa-Honkanen; Kirsi Honkalampi; Sanna Sinikallio; Heimo Viinamäki
Journal:  BMC Public Health       Date:  2009-11-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.